Haemostatic properties of human plasma subjected to a sterilizing dose of gamma irradiation in the presence of ascorbate

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 3, 2007, Pages 271-277

  Zbikowska, Halina Malgorzata ^a   Nowak, Pawel ^a   Wachowicz, Barbara ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Ascorbate; Coagulation fibrinolytic activity; Fibrinogen; Gamma irradiation; Plasminogen; Virus inactivated plasma

Indexed keywords

ASCORBIC ACID; CARBON DIOXIDE; COBALT 60; FIBRINOGEN; FRESH FROZEN PLASMA; PLASMA PROTEIN; PLASMIN; PLASMINOGEN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; DRUG EFFECT; FIBRINOLYSIS; GAMMA IRRADIATION; HEMOCONCENTRATION; HEMOSTASIS; HUMAN; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIATION DOSE; VIRAL CONTAMINATION; VIRUS INACTIVATION;

ASCORBIC ACID; BLOOD PROTEINS; FIBRINOGEN; GAMMA RAYS; HEMOSTASIS; HUMANS; PLASMA; STERILIZATION;

EID: 34247138424     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3280a69148     Document Type: Article

References (41)

1. Snyder EL, Dodd RY. Reducing the risk of blood transfusion. Hematol Am Soc Hematol Educ Program 2001;433-442.
2. Allain JP, Bianco C, Blajchman MA, Brecher ME, Busch M, Leiby D, et al. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 2005; 19:110-126.
3. MacLennan S, Barbara JA. Risks and side effects of therapy with plasma and plasma fractions. Best Pract Res Clin Haematol 2006; 19:169-189.
4. Pelletier JP, Transue S, Snyder EL. Pathogen inactivation techniques. Best Pract Res Clin Haematol 2006; 19:205-242.
5. Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med 1994; 120:1-7.
6. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R, et al. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Transfusion 1997; 37:517-522.
7. Koenigbauer UF, Eastlund T, Day JW. Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 2000; 40:1203-1206.
8. Blumel J, Schmidt I, Effenberger W, Seitz H, Willkommen H, Brackmann HH, et al. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 2002; 42:1473-1481.
9. Kasermann F, Wyss K, Kempf C. Virus inactivation and protein modifications by ethyleneimines. Antiviral Res 2001; 52:33-41.
10. de Alarcon P, Benjamin R, Dugdale M, Kessler C, Shopnick R, Smith P, et al. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion 2005; 45:1362-1372.
11. Yarranton H, Lawrie AS, Mackie IJ, Pinkoski L, Corash L, Machin SJ. Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. Transfusion 2005; 45:1453-1458.
12. Miekka SI, Busby TF, Reid B, Pollock R, Ralston A, Drohan WN. New methods for inactivation of lipid-enveloped and non-enveloped viruses. Haemophilia 1998; 4:402-408.
13. + cells. Transfusion 2001; 41:456-461.
14. Reid BD. The Sterways process: a new approach to inactivating viruses using gamma radiation. Biologicals 1998; 26:125-129.
15. Grieb T, Forng RY, Brown R, Owolabi T, Maddox E, McBain A, et al. Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations. Biologicals 2002; 30:207-216.
16. Amareld RW Jr, Wersocki M, Drohan M, Drohan WN, Burgess WH, Mann DM, et al. Controlled gamma-irradiation mediated pathogen inactivation of human urokinase preparations with significant recovery of enzymatic activity. Biologicals 2003; 31:261-264.
17. Tran H, Marlowe K, McKenney K, Petrosian G, Griko Y, Burgess WH, et al. Functional integrity of intravenous immunoglobulin following irradiation with a virucidal dose of gamma radiation. Biologicals 2004; 32:94-104.
18. Zeiler T, Riess H, Wittmann G, Hintz G, Zimmermann R, Muller C, et al. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion 1994; 34:685-689.
19. Aznar JA, Bonanad S, Montoro JM, Hurtado C, Cid AR, Soler MA, et al. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants. Vox Sang 2000; 79:156-160.
20. Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity. Blood 1999; 94:3922-3927.
21. Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003; 14:283-287.
22. Miekka SI, Forng RY, Rohwer RG, MacAuley C, Stafford RE, Flack SL, et al. Inactivation of viral and prion pathogens by gamma-irradiation under conditions that maintain the integrity of human albumin. Vox Sang 2003; 84:36-44.
23. Zbikowska HM, Nowak P, Wachowicz B. Protein modification caused by a high dose of gamma irradiation in cryo-sterilized plasma: protective effects of ascorbate. Free Radic Biol Med 2006; 40:536-542.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
25. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:4350-4354.
26. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17:237-246.
27. Kempner ES. Effects of high-energy electrons and gamma rays directly on protein molecules. J Pharm Sci 2001; 90:1637-1646.
28. Le Maire M, Thauvette L, de Foresta B, Viel A, Beauregard G, Potier M. Effects of ionizing radiations on proteins. Evidence of non-random fragmentations and a caution in the use of the method for determination of molecular mass. Biochem J 1990; 267:431-439.
29. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324:1-18.
30. Gebicki S, Gebicki JM. Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem J 1993; 289:743-749.
31. Headlam HA, Davies MJ. Beta-scission of side-chain alkoxyl radicals on peptides and proteins results in the loss of side-chains as aldehydes and ketones. Free Radic Biol Med 2002; 32:1171-1184.
32. Filali-Mouhim A, Audette M, St Louis M, Thauvette L, Denoroy L, Penin F, et al. Lysozyme fragmentation induced by gamma-radiolysis. Int J Radiat Biol 1997; 72:63-70.
33. Shacter E, Williams JA, Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 1995; 18:815-821.
34. Aznar JA, Molina R, Montoro JM. Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma. Transfusion 1999; 39:748-750.
35. Depasse F, Sensebe L, Seghatchian J, Andreu G, Samama MM. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices. Transfus Apher Sci 2005; 33:63-69.
36. Lambrecht B, Mohr H, Knuver-Hopf J, Schmitt H. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 1991; 60:207-213.
37. Suontaka AM, Blomback M, Chapman J. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light. Transfusion 2003; 43:568-575.
38. Belisario MA, Di Domenico C, Pelagalli A, Della MR, Staiano N. Metal-ion catalyzed oxidation affects fibrinogen activity on platelet aggregation and adhesion. Biochimie 1997; 79:449-455.
39. Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res 1996; 145:532-541.
40. Blomback B. Fibrinogen and fibrin - proteins with complex roles in hemostasis and thrombosis. Thromb Res 1996; 83:1-75.
41. Lind SE, McDonagh JR, Smith CJ. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate. Blood 1993; 82:1522-1531.